S211 Analyze of risk factors affecting the outcomes of Docetaxel – Prednisolone combination in the treatment of metastatic castration-resistant prostate cancer: A single center study
| Autor: | Arslan, B., Gunlusoy, B., Degirmenci, T., Kozacioglu, Z., Bozkurt, I.H., Yonguc, T., Yarimoglu, S. |
|---|---|
| Zdroj: | In European Urology Supplements October 2013 12(4):e1319 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect